“…In the 35 articles on NMES in pediatric patients without CP, there were a total of 353 participants (293 unique participants) with a mean age of 7 years 4 months (range 1wk-38y). All but one study had participants who were 22 years old or younger; participants in the Oshima et al study 29 had a mean age of 18 years 7 months and all had strokes at age 18 years or younger, but several were older than 22 years at the time of intervention. Demographics of the patients are summarized in Table S1 with studies sorted by target condition and author.…”
Section: Resultsmentioning
confidence: 99%
“…In the 35 articles 24–58 on NMES in pediatric patients without CP, there were a total of 353 participants (293 unique participants) with a mean age of 7 years 4 months (range 1wk–38y). All but one study had participants who were 22 years old or younger; participants in the Oshima et al.…”
Section: Resultsmentioning
confidence: 99%
“…All but one study had participants who were 22 years old or younger; participants in the Oshima et al. study 29 had a mean age of 18 years 7 months and all had strokes at age 18 years or younger, but several were older than 22 years at the time of intervention. Demographics of the patients are summarized in Table S1 with studies sorted by target condition and author.…”
Aim
To explore the breadth of pediatric neurological conditions for which neuromuscular electrical stimulation (NMES) has been studied.
Method
Databases (PubMed, Google Scholar, Scopus, and Embase) were searched from 2000 to 2020, using the search terms ‘neuromuscular electrical stimulation’ OR ‘functional electrical stimulation’ with at least one of the words ‘pediatric OR child OR children OR adolescent’, and without the words ‘dysphagia OR implanted OR enuresis OR constipation’. Articles focused on adults or individuals with cerebral palsy (CP) were excluded.
Results
Thirty‐five studies met the inclusion criteria, with a total of 353 pediatric participants (293 unique participants; mean age 7y 4mo, range 1wk–38y). NMES was applied in a range of pediatric conditions other than CP, including stroke, spinal cord injury, myelomeningocele, scoliosis, congenital clubfoot, obstetric brachial plexus injury, genetic neuromuscular diseases, and other neuromuscular conditions causing weakness.
Interpretation
All 35 studies concluded that NMES was well‐tolerated and most studies suggested that NMES could augment traditional therapy methods to improve strength. Outcome measurements were heterogeneous. Further research on NMES with larger, randomized studies will help clarify its potential to improve physiology and mobility in pediatric patients with neuromuscular conditions.
Neuromuscular electrical stimulation (NMES) appears to be tolerated by pediatric patients.
NMES shows potential for augmenting recovery in pediatric patients with a range of rehabilitation needs.
“…In the 35 articles on NMES in pediatric patients without CP, there were a total of 353 participants (293 unique participants) with a mean age of 7 years 4 months (range 1wk-38y). All but one study had participants who were 22 years old or younger; participants in the Oshima et al study 29 had a mean age of 18 years 7 months and all had strokes at age 18 years or younger, but several were older than 22 years at the time of intervention. Demographics of the patients are summarized in Table S1 with studies sorted by target condition and author.…”
Section: Resultsmentioning
confidence: 99%
“…In the 35 articles 24–58 on NMES in pediatric patients without CP, there were a total of 353 participants (293 unique participants) with a mean age of 7 years 4 months (range 1wk–38y). All but one study had participants who were 22 years old or younger; participants in the Oshima et al.…”
Section: Resultsmentioning
confidence: 99%
“…All but one study had participants who were 22 years old or younger; participants in the Oshima et al. study 29 had a mean age of 18 years 7 months and all had strokes at age 18 years or younger, but several were older than 22 years at the time of intervention. Demographics of the patients are summarized in Table S1 with studies sorted by target condition and author.…”
Aim
To explore the breadth of pediatric neurological conditions for which neuromuscular electrical stimulation (NMES) has been studied.
Method
Databases (PubMed, Google Scholar, Scopus, and Embase) were searched from 2000 to 2020, using the search terms ‘neuromuscular electrical stimulation’ OR ‘functional electrical stimulation’ with at least one of the words ‘pediatric OR child OR children OR adolescent’, and without the words ‘dysphagia OR implanted OR enuresis OR constipation’. Articles focused on adults or individuals with cerebral palsy (CP) were excluded.
Results
Thirty‐five studies met the inclusion criteria, with a total of 353 pediatric participants (293 unique participants; mean age 7y 4mo, range 1wk–38y). NMES was applied in a range of pediatric conditions other than CP, including stroke, spinal cord injury, myelomeningocele, scoliosis, congenital clubfoot, obstetric brachial plexus injury, genetic neuromuscular diseases, and other neuromuscular conditions causing weakness.
Interpretation
All 35 studies concluded that NMES was well‐tolerated and most studies suggested that NMES could augment traditional therapy methods to improve strength. Outcome measurements were heterogeneous. Further research on NMES with larger, randomized studies will help clarify its potential to improve physiology and mobility in pediatric patients with neuromuscular conditions.
Neuromuscular electrical stimulation (NMES) appears to be tolerated by pediatric patients.
NMES shows potential for augmenting recovery in pediatric patients with a range of rehabilitation needs.
“…Several clinical trials of robot-assisted gait training have been reported in neurology patients. [1][2][3][4] In particular, the Hybrid Assistive Limb (HAL) gait training has resulted in improved gait and balance performance. 1,3,5 The HAL exoskeleton is completely driven by the patient's own muscle activation, which is detected by surface electrodes on key lower extremity muscle groups.…”
Background: Despite the potential benefits, the effects of Hybrid Assistive Limb (HAL) gait training on changes in neuromuscular activation that accompany functional gains in individuals with spinal muscular atrophy (SMA) type III is not well known. In this article, we quantify the effects of HAL gait training on spatial muscle activity patterns in a patient with SMA type III using multi-channel surface electromyography (SEMG). Methods: A 21-years old male (168 cm, 47.8 kg) with spinal muscular atrophy type III, when diagnosed at 18-years old by genetic screening, participated in this case study. Although he presented with forearm distal muscle weakness, atrophy of the intrinsic muscles of the hand, and neuromuscular fatigue, his activities of daily living is independent. The patient underwent a separate, single 33-minute session of both HAL and treadmill gait training. To evaluate the coefficient of variation (CoV) of force and alterations in the SEMG spatial distribution patterns, modified entropy and CoV of root mean square (RMS) were calculated from the vastus lateralis (VL) muscle before and after the intervention of HAL and treadmill gait training. Each training session was separated by a period of one month to avoid cross-over effects. Results: There was a greater decrease in the ΔCoV of force and an increase in the magnitude of whole VL muscle activation from pre-intervention to post-intervention with the HAL gait training as compared to the treadmill gait training. In response to only HAL gait training, the CoV of RMS was higher, and the modified entropy was lower post-intervention than pre-intervention. Conclusions: Our results support the notion that HAL gait training has a positive benefit on motor output not only in the magnitude of SEMG generated but also the patterns of neural activation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.